Your browser doesn't support javascript.
loading
Testing the Shamiri Intervention and Its Components With Kenyan Adolescents During the COVID-19 Pandemic: Outcomes of a Universal, 5-Arm Randomized Controlled Trial.
Venturo-Conerly, Katherine E; Osborn, Tom L; Rusch, Thomas; Ochuku, Brenda Kemuma; Johnson, Natalie E; van der Markt, Afra; Wasanga, Christine M; Weisz, John R.
Afiliação
  • Venturo-Conerly KE; Shamiri Institute, Nairobi, Kenya; Harvard University, Cambridge Massachusetts. Electronic address: kventuroconerly@g.harvard.edu.
  • Osborn TL; Shamiri Institute, Nairobi, Kenya.
  • Rusch T; Competence Center for Empirical Research Methods, WU Vienna University of Economics and Business, Vienna, Austria.
  • Ochuku BK; Shamiri Institute, Nairobi, Kenya.
  • Johnson NE; Shamiri Institute, Nairobi, Kenya; University Hospital Basel, Basel, Switzerland.
  • van der Markt A; Shamiri Institute, Nairobi, Kenya.
  • Wasanga CM; Shamiri Institute, Nairobi, Kenya; Kenyatta University, Nairobi, Kenya.
  • Weisz JR; Harvard University, Cambridge Massachusetts.
Article em En | MEDLINE | ID: mdl-38851382
ABSTRACT

OBJECTIVE:

Mental health problems are prevalent among African adolescents, but professional treatment capacity is limited. Shamiri, an efficient lay provider-delivered intervention, has significantly reduced depression and anxiety symptoms in previous randomized controlled trials (RCTs). This trial investigated effects of the full Shamiri intervention and its components (growth-only, gratitude-only, and values-only) against a study skills control.

METHOD:

In a 5-group RCT with adolescents from Kenyan high schools, anxiety, depression, and well-being were self-reported through 8-month follow-up. The RCT occurred immediately after an unanticipated government-mandated COVID-19 shutdown forced 3 years of schoolwork into 2 years, escalating academic pressures.

RESULTS:

Participants (N = 1,252; 48.72% female) were allocated to growth (n = 249), gratitude (n = 237), values (n = 265), Shamiri (n = 250), and study skills (n = 251) conditions. Longitudinal multilevel models showed that, across all conditions, anxiety scores significantly improved at midpoint (B = -0.847), end point (B = -2.948), 1-month (B = -1.587), 3-month (B = -2.374), and 8-month (B = -1.917) follow-ups. Depression scores also improved significantly at midpoint (B = -0.796), end point (B = -3.126), 1-month (B = -2.382), 3-month (B = -2.521), and 8-month (B = -2.237) follow-ups. Well-being scores improved significantly at midpoint (B = 1.73), end point (B = 3.44), 1-month (B = 2.21), 3-month (B = 1.78), and 8-month (B = 1.59) follow-ups. Symptom reduction with Shamiri matched that of pre-COVID-19 trials, but symptom reduction with study skills far outpaced that of trials before the COVID-19-related school shutdown (31% greater anxiety reduction and 60% greater depression reduction). Thus, in contrast to previous RCTs, this COVID-19-era trial showed no significant differences between outcomes in any intervention and active control groups.

CONCLUSION:

Our RCT conducted during a post-COVID-19 period of heightened academic pressure produced unexpected results. Improvements in youth-reported anxiety and depression were consistent with previous trials for Shamiri, but markedly larger than in previous trials for study skills. Control interventions teaching life skills may produce mental health benefits when they convey skills of particular contextual relevance. CLINICAL TRIAL REGISTRATION Five-Arm Shamiri Trial; https//pactr.samrc.ac.za/; PACTR202104716135752.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article